Movatterモバイル変換


[0]ホーム

URL:


Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
Thehttps:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log inShow account info
Access keysNCBI HomepageMyNCBI HomepageMain ContentMain Navigation
pubmed logo
Advanced Clipboard
User Guide

Full text links

Nature Publishing Group full text link Nature Publishing Group
Full text links

Actions

Share

.2024 Sep 5:10.1038/s41587-024-02370-5.
doi: 10.1038/s41587-024-02370-5. Online ahead of print.

Continuous multiplexed phage genome editing using recombitrons

Affiliations

Continuous multiplexed phage genome editing using recombitrons

Chloe B Fishman et al. Nat Biotechnol..

Abstract

Bacteriophage genome editing can enhance the efficacy of phages to eliminate pathogenic bacteria in patients and in the environment. However, current methods for editing phage genomes require laborious screening, counterselection or in vitro construction of modified genomes. Here, we present a scalable approach that uses modified bacterial retrons called recombitrons to generate recombineering donor DNA paired with single-stranded binding and annealing proteins for integration into phage genomes. This system can efficiently create genome modifications in multiple phages without the need for counterselection. The approach also supports larger insertions and deletions, which can be combined with simultaneous counterselection for >99% efficiency. Moreover, we show that the process is continuous, with more edits accumulating the longer the phage is cultured with the host, and multiplexable. We install up to five distinct mutations on a single lambda phage genome without counterselection in only a few hours of hands-on time and identify a residue-level epistatic interaction in the T7 gp17 tail fiber.

© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.

PubMed Disclaimer

Conflict of interest statement

Competing Interests

C.B.F., S.B.K., and S.L.S. are named inventors on a patent application related to the technologies described in this work.

Update of

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Strathdee SA, Hatfull GF, Mutalik VK & Schooley RT Phage therapy: From biological mechanisms to future directions. Cell 186, 17–31, doi:10.1016/j.cell.2022.11.017 (2023). - DOI - PMC - PubMed
    1. Mahler M, Costa AR, van Beljouw SPB, Fineran PC & Brouns SJJ Approaches for bacteriophage genome engineering. Trends in biotechnology, doi:10.1016/j.tibtech.2022.08.008 (2022). - DOI - PubMed
    1. Simon AJ, Ellington AD & Finkelstein IJ Retrons and their applications in genome engineering. Nucleic Acids Res 47, 11007–11019, doi:10.1093/nar/gkz865 (2019). - DOI - PMC - PubMed
    1. Żaczek M, Weber-Dąbrowska B, Międzybrodzki R, Łusiak-Szelachowska M & Górski A Phage Therapy in Poland - a Centennial Journey to the First Ethically Approved Treatment Facility in Europe. Frontiers in microbiology 11, 1056, doi:10.3389/fmicb.2020.01056 (2020). - DOI - PMC - PubMed
    1. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet (London, England) 399, 629–655, doi:10.1016/s0140-6736(21)02724-0 (2022). - DOI - PMC - PubMed

Related information

Grants and funding

LinkOut - more resources

Full text links
Nature Publishing Group full text link Nature Publishing Group
Cite
Send To

NCBI Literature Resources

MeSHPMCBookshelfDisclaimer

The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.


[8]ページ先頭

©2009-2025 Movatter.jp